ISCI Announces Global Physician Network
12 Febbraio 2013 - 1:30PM
Marketwired
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the
Company) announced today that The Integrative Stem Cell Institute
(ISCI), a premier provider of point-of-care, stem cell-based
therapies, has launched a global physician's network, to connect
international patients to local physicians, and to link physicians
to opportunities for education, training and collaboration in
regenerative medicine.
ISCI has formed The International Stem Cell Practice (ISCP) to
meet two very specific needs in the field of stem cell medicine:
physician education and patient follow up. With the creation of
this global network, the ISCI hopes to provide a highly scalable
and versatile solution to serve the needs of both of these crucial
audiences.
Working with a state-of-the art laboratory and a fully
integrative medical facility in Cancun, Mexico, the ISCI and the
ISCP will provide a venue for hands-on training in regenerative
medicine as well as educational opportunities for physicians to
exchange best practices and explore emerging trends in the field.
The ISCP will also be hosting a series of regional meetings
throughout the United States and Latin America to foster
professional collaboration.
The main focus of the network, however, will be providing
initial evaluation and long-term follow up for patients
participating in the clinical studies of the ISCI. Members of the
ISCP will work directly with the ISCI in providing medical
oversight and care to patients participating in clinical
studies.
"Long-term follow and data collection have always been one of
the weakest elements of regenerative medicine," says David Audley,
CEO of the ISCI. "This has been exacerbated by the fact that most
patients must travel a great distance to get treatments, and it is
next to impossible for the clinics to conduct thorough follow up."
By connecting the patient to a local physician prior to their
treatment, the ISCI assures not only that a thorough and
independent evaluation of the patient is taken but also that it is
logistically feasible for patients to visit a physician for
post-treatment follow up and testing. "This network, with its
connection between patients and local physicians, provides the
final piece that has been missing in stem cell medicine," continues
Mr. Audley. "This will allow us to finally collect the data needed
to evidence outcomes and advance the field."
About Integrative Stem Cell Institute
(ISCI) The Integrative Stem Cell Institute (ISCI) is a premier
provider of point-of-care, stem cell-based therapies for patients
from around the world. With a state of the art laboratory housed
within the Hospital Galenia in Cancun, Mexico, the ISCI combines
the most advanced scientific application of stem cells with second
to none medical care within the structure of adaptive clinical
trials to effectively track long term outcomes and assure patient
safety. More information on the Integrative Stem Cell Institute is
available at www.iscelli.com
SAFE HARBOR STATEMENT
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, adequate financing, and
other material risks. Such forward-looking statements by definition
involve risks, uncertainties and other factors, which may cause the
actual results, performance, or achievements to be materially
different from the statements made herein. Contact:
The Integrative Stem Cell Institute Contact: Miranda Abrahams
Miranda@iscelli.com Investor Contact Atlanta Capital Partners, LLC
David Kugelman (866) 692-6847 info@atlcp.com
Grafico Azioni Profile Solutions (CE) (USOTC:PSIQ)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Profile Solutions (CE) (USOTC:PSIQ)
Storico
Da Giu 2023 a Giu 2024